Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR006298)
Formula
CYP
SVG example
Reactant Fenethylline Product Fenethylline Metabolite M-1(AP )
Reactant Info Product Info
Metabolic Enzyme Cytochrome P450 (CYP) DME Info
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR006300 Fenethylline Fenethylline Metabolite M-3( hydroxyethyl-TP) Unclear Fenethylline [1]
MR006296 Fenethylline Fenethylline Metabolite M-4(aminoethyl-TP) Unclear Fenethylline [1]
MR006301 Fenethylline Fenethylline Metabolite M-6( carboxymethyl-TP) Unclear Fenethylline [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR005723 Benzphetamine Amphetamine Unclear Benzphetamine [2]
MR004247 Etilamfetamine Amphetamine Unclear Etilamfetamine [3]
MR007177 Famprofazone Amphetamine Oxidation - N-dealkylation Famprofazone [4]
MR009984 Metamfetamine Amphetamine Unclear - Unclear Metamfetamine [5], [6], [7]
MR010000 Methamphetamine hydrochloride Amphetamine Unclear - Unclear Methamphetamine hydrochloride [5], [6], [7]
MR010844 Desmethyl selegiline Amphetamine Unclear - Unclear Selegiline [8]
MR007170 Methamphetamine Amphetamine Oxidation - N-demethylation Famprofazone [4]
MR010842 Methamphetamine Amphetamine Unclear - Unclear Selegiline [8]
⏷ Show the Full List of MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR006299 Fenethylline Metabolite M-1(AP ) Fenethylline Metabolite M-5( p-hydroxy-AP) Unclear Fenethylline [1]
References
1 Metabolic fate of fenetylline in rat and man
2 DrugBank(Pharmacology-Metabolism):Benzphetamine
3 The influence of diuretics on the excretion and metabolism of doping agents. III. Etilamfetamine. Arzneimittelforschung. 1986 Sep;36(9):1413-6.
4 Identification of new urinary metabolites of famprofazone in humans
5 Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in rats
6 Drugs of abuse in a non-conventional sample; detection of methamphetamine and its main metabolite, amphetamine in abusers' clothes by HPLC with UV and fluorescence detection
7 Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependence
8 Physiologically Based Pharmacokinetic Modeling of Transdermal Selegiline and Its Metabolites for the Evaluation of Disposition Differences between Healthy and Special Populations

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.